BNP Paribas Financial Markets’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $90.7K | Buy |
37,780
+20,230
| +115% | +$39.4K | ﹤0.01% | 4609 |
|
|
2026
Q1 | $27.4K | Buy |
17,550
+17,539
| +159,445% | +$25.5K | ﹤0.01% | 4983 |
|
|
2025
Q4 | $13 | Sell |
11
-4,977
| -100% | -$6.84K | ﹤0.01% | 5686 |
|
|
2025
Q3 | $6.73K | Sell |
4,988
-3,715
| -43% | -$4.22K | ﹤0.01% | 5066 |
|
|
2025
Q2 | $8.23K | Sell |
8,703
-80,411
| -90% | -$52.1K | ﹤0.01% | 4888 |
|
|
2025
Q1 | $41.1K | Buy |
89,114
+69,410
| +352% | +$43.8K | ﹤0.01% | 4347 |
|
|
2024
Q4 | $14.6K | Sell |
19,704
-12,149
| -38% | -$14.6K | ﹤0.01% | 4779 |
|
|
2024
Q3 | $50K | Buy |
31,853
+13,246
| +71% | +$23.6K | ﹤0.01% | 3613 |
|
|
2024
Q2 | $31.3K | Sell |
18,607
-40,771
| -69% | -$73.1K | ﹤0.01% | 3572 |
|
|
2024
Q1 | $143K | Buy |
59,378
+26,859
| +83% | +$57.7K | ﹤0.01% | 3343 |
|
|
2023
Q4 | $49.8K | Sell |
32,519
-88,053
| -73% | -$105K | ﹤0.01% | 3567 |
|
|
2023
Q3 | $131K | Buy |
120,572
+95,432
| +380% | +$167K | ﹤0.01% | 3248 |
|
|
2023
Q2 | $57.6K | Buy |
25,140
+6,588
| +36% | +$17.5K | ﹤0.01% | 3426 |
|
|
2023
Q1 | $45.1K | Buy |
18,552
+10,312
| +125% | +$23.6K | ﹤0.01% | 3441 |
|
|
2022
Q4 | $15.7K | Sell |
8,240
-7,219
| -47% | -$15.4K | ﹤0.01% | 3570 |
|
|
2022
Q3 | $37.1K | Sell |
15,459
-644
| -4% | -$1.78K | ﹤0.01% | 4032 |
|
|
2022
Q2 | $30K | Sell |
16,103
-90,461
| -85% | -$173K | ﹤0.01% | 3653 |
|
|
2022
Q1 | $223K | Buy |
106,564
+3,220
| +3% | +$8.93K | ﹤0.01% | 3086 |
|
|
2021
Q4 | $407K | Buy |
103,344
+88,103
| +578% | +$428K | ﹤0.01% | 3102 |
|
|
2021
Q3 | $73.3K | Buy |
15,241
+12,484
| +453% | +$51.2K | ﹤0.01% | 3399 |
|
|
2021
Q2 | $12.7K | Sell |
2,757
-4,041
| -59% | -$19.5K | ﹤0.01% | 3665 |
|
|
2021
Q1 | $39.9K | Sell |
6,798
-1,057
| -13% | -$7.32K | ﹤0.01% | 3657 |
|
|
2020
Q4 | $26.9K | Sell |
7,855
-1,672
| -18% | -$3.19K | ﹤0.01% | 3782 |
|
|
2020
Q3 | $13.7K | Buy |
9,527
+6,653
| +231% | +$11.8K | ﹤0.01% | 3917 |
|
|
2020
Q2 | $5.73K | Sell |
2,874
-10,846
| -79% | -$21.3K | ﹤0.01% | 3951 |
|
|
2020
Q1 | $26.8K | Buy |
13,720
+7,992
| +140% | +$23.8K | ﹤0.01% | 3823 |
|
|
2019
Q4 | $23.8K | Sell |
5,728
-1,986
| -26% | -$7.64K | ﹤0.01% | 3947 |
|
|
2019
Q3 | $23.2K | Buy |
7,714
+2,021
| +35% | +$6.26K | ﹤0.01% | 3884 |
|
|
2019
Q2 | $35.8K | Sell |
5,693
-4,241
| -43% | -$25.4K | ﹤0.01% | 3627 |
|
|
2019
Q1 | $55.2K | Buy |
9,934
+8,979
| +940% | +$54.5K | ﹤0.01% | 3446 |
|
|
2018
Q4 | $6.34K | Sell |
955
-1,661
| -63% | -$13.5K | ﹤0.01% | 3497 |
|
|
2018
Q3 | $27.9K | Buy |
2,616
+184
| +8% | +$2.11K | ﹤0.01% | 3280 |
|
|
2018
Q2 | $29.2K | Sell |
2,432
-6,948
| -74% | -$71.1K | ﹤0.01% | 3340 |
|
|
2018
Q1 | $80.4K | Buy |
9,380
+184
| +2% | +$1.7K | ﹤0.01% | 3304 |
|
|
2017
Q4 | $90.9K | Buy |
9,196
+4,061
| +79% | +$42.2K | ﹤0.01% | 3352 |
|
|
2017
Q3 | $63.1K | Sell |
5,135
-311
| -6% | -$4.59K | ﹤0.01% | 3026 |
|
|
2017
Q2 | $89.6K | Buy |
5,446
+4,537
| +499% | +$70.3K | ﹤0.01% | 2872 |
|
|
2017
Q1 | $13K | Sell |
909
-464
| -34% | -$6.88K | ﹤0.01% | 3128 |
|
|
2016
Q4 | $19K | Sell |
1,373
-2,148
| -61% | -$34.5K | ﹤0.01% | 3205 |
|
|
2016
Q3 | $63.6K | Buy |
3,521
+1,873
| +114% | +$30.1K | ﹤0.01% | 2324 |
|
|
2016
Q2 | $23.6K | Buy |
+1,648
| New | +$22.4K | ﹤0.01% | 2523 |
|
|
2016
Q1 | – | Sell |
-9,016
| Closed | -$120K | – | 2904 |
|
|
2015
Q4 | $120K | Buy |
9,016
+170
| +2% | +$2.09K | ﹤0.01% | 2209 |
|
|
2015
Q3 | $95K | Buy |
+8,846
| New | +$96.6K | ﹤0.01% | 2427 |
|
|
2015
Q2 | – | Sell |
-824
| Closed | -$5.42K | – | 3588 |
|
|
2015
Q1 | $5.42K | Buy |
+824
| New | +$5.63K | ﹤0.01% | 3108 |
|
|
2014
Q4 | – | Sell |
-1,921
| Closed | -$19K | – | 2668 |
|
|
2014
Q3 | $19K | Buy |
+1,921
| New | +$20.5K | ﹤0.01% | 3207 |
|
|
2014
Q2 | – | Sell |
-150
| Closed | -$1.61K | – | 3893 |
|
|
2014
Q1 | $1.61K | Sell |
150
-346
| -70% | -$4.42K | ﹤0.01% | 2727 |
|
|
2013
Q4 | $6.25K | Sell |
496
-8,555
| -95% | -$136K | ﹤0.01% | 2950 |
|
|
2013
Q3 | $151K | Sell |
9,051
-1,902
| -17% | -$31.9K | ﹤0.01% | 2335 |
|
|
2013
Q2 | $166K | Buy |
+10,953
| New | +$166K | ﹤0.01% | 2403 |
|
Other funds holding LXRX
AG
SL
VCM
VPM
BNP Paribas Financial Markets's LXRX Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Lexicon Pharmaceuticals (LXRX) stake by 115% in Q2 2026, buying an estimated $39.4K and bringing the position to 37,780 shares worth $90.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4609.
BNP Paribas Financial Markets first reported a position in LXRX in Q2 2013 and has held it in 49 quarters since. The position peaked at $407K in Q4 2021. 139 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.
- BNP Paribas Financial Markets held 37,780 shares of Lexicon Pharmaceuticals worth $90.7K as of Q2 2026.
- BNP Paribas Financial Markets bought 20,230 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $39.4K.
- Lexicon Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4609 holding.
- BNP Paribas Financial Markets first reported a position in Lexicon Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
- BNP Paribas Financial Markets's Lexicon Pharmaceuticals position peaked at $407K in Q4 2021.
- 139 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.